Vijay K Lathi - Insider Trading Tracker

iRhythm Technologies, Inc.

US ˙ NasdaqGS ˙ US4500561067

Pengenalan

Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Vijay K Lathi. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.

Purata Keuntungan Perdagangan

Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.

Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.

Kekerapan Kemas Kini: Harian

Lihat senarai pedagang dalaman yang paling menguntungkan.

Lihat Orang Dalam Dengan Kedudukan Tertinggi

Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan

Pemfailan SEC menunjukkan Vijay K Lathi telah melaporkan pegangan atau perdagangan dalam syarikat berikut:

Sekuriti	Tajuk	Pegangan Terkini Dilaporkan
US:HARP / Harpoon Therapeutics, Inc.	Director, 10% Owner	0
US:ITRM / Iterum Therapeutics plc	10% Owner	0
US:IRTC / iRhythm Technologies, Inc.	Director	0
US:MEIP / MEI Pharma, Inc.	10% Owner	0
US:VSAR / Versartis, Inc..	10% Owner	2,409,374
US:DRTX / Durata Therapeutics Inc	10% Owner	0
US:CMRX / Chimerix, Inc.	10% Owner	1,543,394
US:CNCE / Concert Pharmaceuticals Inc	10% Owner	0
	Director, 10% Owner	1,377,497
US:RLYP / Relypsa, Inc.		0
	10% Owner	0
US:TSPT /	10% Owner	1,636,982

Bagaimana Mentafsir Carta

Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Vijay K Lathi. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.

Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.

Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.

Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.

Pembelian Orang Dalam IRTC / iRhythm Technologies, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam IRTC / iRhythm Technologies, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Maks	Harga pada Maks	Maks Keuntungan ($)	Pulangan Maks (%)
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam IRTC / iRhythm Technologies, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam IRTC / iRhythm Technologies, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2018-03-09 IRTC Lathi Vijay K 84,380 66.3969 84,380 66.3969 5,602,570 47 57.89 -717,812 -12.81

2018-03-08 IRTC Lathi Vijay K 26,979 66.5004 26,979 66.5004 1,794,114

2018-03-08 IRTC Lathi Vijay K 2,659 67.1704 2,659 67.1704 178,606

2018-02-22 IRTC Lathi Vijay K 45,723 65.6133 45,723 65.6133 3,000,037

2018-02-21 IRTC Lathi Vijay K 44,000 64.1162 44,000 64.1162 2,821,113

2018-02-20 IRTC Lathi Vijay K 125,000 61.8091 125,000 61.8091 7,726,138

2017-12-07 IRTC Lathi Vijay K 6,354 52.1495 6,354 52.1495 331,358

2017-12-07 IRTC Lathi Vijay K 72,000 52.7846 72,000 52.7846 3,800,491

2017-12-06 IRTC Lathi Vijay K 14,216 52.2855 14,216 52.2855 743,291

2017-12-05 IRTC Lathi Vijay K 57,430 52.4082 57,430 52.4082 3,009,803

2017-11-17 IRTC Lathi Vijay K 125,000 52.1102 125,000 52.1102 6,513,775

2017-11-16 IRTC Lathi Vijay K 100,000 52.0866 100,000 52.0866 5,208,660

2017-09-13 IRTC Lathi Vijay K 10 45.8240 10 45.8240 458

2017-09-13 IRTC Lathi Vijay K 34,603 49.5090 34,603 49.5090 1,713,160

2017-06-08 IRTC Lathi Vijay K 292,000 38.0400 292,000 38.0400 11,107,680

2017-06-06 IRTC Lathi Vijay K 138,624 36.6300 138,624 36.6300 5,077,797

2017-05-16 IRTC Lathi Vijay K 80,000 36.2600 80,000 36.2600 2,900,800

2017-05-16 IRTC Lathi Vijay K 130,000 35.2500 130,000 35.2500 4,582,500

2017-05-15 IRTC Lathi Vijay K 235,000 34.2500 235,000 34.2500 8,048,750

2017-05-12 IRTC Lathi Vijay K 200,000 34.2500 200,000 34.2500 6,850,000

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Pembelian Orang Dalam MEIP / MEI Pharma, Inc. - Analisis Keuntungan Jangka Pendek

Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam IRTC / iRhythm Technologies, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .

Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Maks Harga pada
Maks Maks
Keuntungan ($) Pulangan Maks (%)

Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Jualan Orang Dalam MEIP / MEI Pharma, Inc. - Analisis Kerugian Jangka Pendek

Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam IRTC / iRhythm Technologies, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .

Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.

Tarikh Dagangan Simbol Saham Orang dalam Saham
Dilaporkan Harga
Dilaporkan Saham
Dilaraskan Harga
Dilaraskan Asas Kos Hari ke
Min Harga pada
Min Kerugian Maks
Dielakkan ($) Kerugian Maks
Dielakkan (%)

2015-03-24 MEIP New Leaf Ventures II, L.P. 1,601,390 1.9734 80,070 39.4680 3,160,183 323 404 29,187,693 923.61

2014-12-09 MEIP New Leaf Ventures II, L.P. 70,081 6.0085 3,504 120.1700 421,082

2014-12-08 MEIP New Leaf Ventures II, L.P. 9,004 6.0523 450 121.0460 54,495

2013-11-21 MEIP New Leaf Ventures II, L.P. 365,000 8.2500 18,250 165.0000 3,011,250

2013-05-08 MEIP New Leaf Ventures II, L.P. 100,000 8.4500 5,000 169.0000 845,000

2013-05-06 MEIP New Leaf Ventures II, L.P. 100,000 8.7000 5,000 174.0000 870,000

2013-04-19 MEIP New Leaf Ventures II, L.P. 157,300 8.4300 7,865 168.6000 1,326,039

2013-04-18 MEIP New Leaf Ventures II, L.P. 100,000 8.5700 5,000 171.4000 857,000

2013-02-19 MEIP New Leaf Ventures II, L.P. 300,000 6.8000 15,000 136.0000 2,040,000

2013-02-15 MEIP New Leaf Ventures II, L.P. 197,225 6.6000 9,861 132.0000 1,301,685

Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.

Sejarah Dagangan Orang Dalam

Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Vijay K Lathi seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).

Tarikh Fail Tarikh Tran Borang Simbol Saham Sekuriti Kod 10b5-1 Saham Baki Saham Peratus
Ubah Saham
harga Tran
Nilai Baki
Nilai

2024-03-11 2024-03-11 4 HARP Harpoon Therapeutics, Inc.
8.000% Series A Redeemable Preferred Stock D - Sale to Issuer -10,000 0 -100.00

2024-03-11 2024-03-11 4 HARP Harpoon Therapeutics, Inc.
Common Stock D - Sale to Issuer -395,783 0 -100.00

2024-03-11 2024-03-11 4 HARP Harpoon Therapeutics, Inc.
Common Stock D - Sale to Issuer -1,463,386 0 -100.00

2023-10-27 2023-10-25 4 HARP Harpoon Therapeutics, Inc.
Common Stock P - Purchase 171,500 395,783 76.47

2023-10-27 2023-10-25 4 HARP Harpoon Therapeutics, Inc.
Common Stock P - Purchase 1,372,000 1,463,386 1,501.32

2023-03-27 3 HARP Harpoon Therapeutics, Inc.
8.000% Series A Redeemable Preferred Stock 10,000

2023-03-27 3 HARP Harpoon Therapeutics, Inc.
Common Stock 913,860

2023-03-27 3 HARP Harpoon Therapeutics, Inc.
Common Stock 2,242,839

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Series B-2 Preferred Shares C - Conversion -148,603 0 -100.00

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Series B-1 Preferred Shares C - Conversion -178,230 0 -100.00

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Series A Preferred Shares C - Conversion -466,793 0 -100.00

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares P - Purchase 384,615 384,615 13.00 4,999,995 4,999,995

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares P - Purchase 278,062 1,071,688 35.04 13.00 3,614,806 13,931,944

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares C - Conversion 148,603 793,626 23.04

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares C - Conversion 178,230 645,023 38.18

2018-05-31 2018-05-30 4 ITRM Iterum Therapeutics plc
Ordinary Shares C - Conversion 466,793 466,793

2018-03-12 2018-03-09 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -84,380 0 -100.00 66.40 -5,602,570

2018-03-12 2018-03-08 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -2,659 84,380 -3.05 67.17 -178,606 5,667,838

2018-03-12 2018-03-08 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -26,979 87,039 -23.66 66.50 -1,794,114 5,788,128

2018-02-26 2018-02-22 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -45,723 114,018 -28.62 65.61 -3,000,037 7,481,097

2018-02-22 2018-02-21 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -44,000 159,741 -21.60 64.12 -2,821,113 10,241,986

2018-02-22 2018-02-20 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -125,000 203,741 -38.02 61.81 -7,726,138 12,593,048

2017-12-07 2017-12-07 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -72,000 328,741 -17.97 52.78 -3,800,491 17,352,462

2017-12-07 2017-12-07 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -6,354 400,741 -1.56 52.15 -331,358 20,898,443

2017-12-07 2017-12-06 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -14,216 407,095 -3.37 52.29 -743,291 21,285,166

2017-12-07 2017-12-05 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -57,430 421,311 -12.00 52.41 -3,009,803 22,080,151

2017-11-20 2017-11-17 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -125,000 478,741 -20.70 52.11 -6,513,775 24,947,289

2017-11-20 2017-11-16 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -100,000 603,741 -14.21 52.09 -5,208,660 31,446,816

2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock Warrant (Right to Buy) X - Other -72,389 0 -100.00

2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -34,603 703,741 -4.69 49.51 -1,713,160 34,841,513

2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -10 738,344 0.00 45.82 -458 33,833,875

2017-09-15 2017-09-13 4 IRTC iRhythm Technologies, Inc.
Common Stock X - Other 72,389 738,354 10.87

2017-07-07 2017-04-26 4 IRTC iRhythm Technologies, Inc.
Employee Stock Option (right to buy) A - Award 3,007 3,007

2017-07-07 2017-04-26 4 IRTC iRhythm Technologies, Inc.
Common Stock A - Award 1,405 1,405

2017-06-08 2017-06-08 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -292,000 665,965 -30.48 38.04 -11,107,680 25,333,309

2017-06-08 2017-06-06 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -138,624 957,965 -12.64 36.63 -5,077,797 35,090,258

2017-05-16 2017-05-16 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -130,000 1,096,589 -10.60 35.25 -4,582,500 38,654,762

2017-05-16 2017-05-16 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -80,000 1,226,589 -6.12 36.26 -2,900,800 44,476,117

2017-05-16 2017-05-15 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -235,000 1,306,589 -15.24 34.25 -8,048,750 44,750,673

2017-05-16 2017-05-12 4 IRTC iRhythm Technologies, Inc.
Common Stock S - Sale -200,000 1,541,589 -11.48 34.25 -6,850,000 52,799,423

2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series D Preferred Stock Warrant (Right to Buy) C - Conversion -72,389 0 -100.00

2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series E Convertible Preferred Stock C - Conversion -155,548 0 -100.00

2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series D Convertible Preferred Stock C - Conversion -190,154 0 -100.00

2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Series C Convertible Preferred Stock C - Conversion -610,136 0 -100.00

2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Common Stock P - Purchase 25,000 1,741,589 1.46 17.00 425,000 29,607,013

2016-10-25 2016-10-25 4 IRTC iRhythm Technologies, Inc.
Common Stock C - Conversion 1,716,589 1,716,589

2015-03-26 2015-03-24 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -1,601,390 0 -100.00 1.97 -3,160,183

2014-12-22 2014-12-18 4 VSAR Versartis, Inc.
Common Stock S - Sale -150,000 2,409,374 -5.86 19.01 -2,851,845 45,807,741

2014-12-10 2014-12-09 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -70,081 1,601,390 -4.19 6.01 -421,082 9,621,952

2014-12-10 2014-12-08 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -9,004 1,671,471 -0.54 6.05 -54,495 10,116,244

2014-11-18 2014-11-17 4 DRTX Durata Therapeutics, Inc.
Common Stock D - Sale to Issuer -3,028,439 0 -100.00

2014-11-13 2014-11-11 4 VSAR Versartis, Inc.
Common Stock S - Sale -800,000 2,559,374 -23.81 19.37 -15,496,000 49,575,074

2014-10-01 2014-09-29 4 VSAR Versartis, Inc.
Common Stock S - Sale -12,556 3,359,374 -0.37 20.02 -251,331 67,243,917

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series B Convertible Preferred Stock C - Conversion -759,565 0 -100.00

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Warrant X - Other -759,565 0 -100.00

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series E Convertible Preferred Stock C - Conversion -3,546,094 0 -100.00

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series D2 Convertible Preferred Stock C - Conversion -1,349,433 0 -100.00

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series D1 Convertible Preferred Stock C - Conversion -3,050,019 0 -100.00

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series C Convertible Preferred Stock C - Conversion -8,439,620 0 -100.00

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Series B Convertible Preferred Stock C - Conversion -20,942,466 0 -100.00

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock P - Purchase 60,000 3,371,930 1.81 21.02 1,261,200 70,877,969

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock C - Conversion 66,049 3,311,930 2.03

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock C - Conversion 308,356 3,245,881 10.50

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock C - Conversion 117,342 2,937,525 4.16

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock C - Conversion 265,219 2,820,183 10.38

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock C - Conversion 733,880 2,554,964 40.30

2014-03-28 2014-03-27 4 VSAR Versartis, Inc.
Common Stock C - Conversion 1,821,084 1,821,084

2014-03-20 2014-03-18 4 CMRX CHIMERIX INC
Common Stock J - Other -700,000 1,543,394 -31.20

2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series C Preferred Stock C - Conversion 77,522 0 -100.00

2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Series B Preferred Stock C - Conversion 442,478 0 -100.00

2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock C - Conversion 13,721 107,327 14.66

2014-02-21 2014-02-19 4 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock C - Conversion 78,315 93,606 512.16

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2014-02-12 3 CNCE CONCERT PHARMACEUTICALS, INC.
Common Stock 30,582

2013-11-25 2013-11-21 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -365,000 1,680,475 -17.84 8.25 -3,011,250 13,863,919

2013-11-21 3 OXFD Oxford Immunotec Global PLC
Ordinary Shares 1,377,497

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Warrant to Purchase Common Stock M - Exercise -25,977 0 -100.00

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Warrant to Purchase Common Stock J - Other 25,977 25,977

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Warrant to Purchase Preferred Stock J - Other -17,671 0 -100.00

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series C-2 Preferred Stock C - Conversion -125,067 0 -100.00

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series C-1 Preferred Stock C - Conversion -541,960 0 -100.00

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series B-2 Preferred Stock C - Conversion -378,773 0 -100.00

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series B-1 Preferred Stock C - Conversion -259,676 0 -100.00

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Series A-1 Preferred Stock C - Conversion -497,093 0 -100.00

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock P - Purchase 185,978 2,114,890 9.64 11.00 2,045,758 23,263,790

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock F - Taxes -21,691 1,928,912 -1.11 11.00 -238,601 21,218,032

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock M - Exercise 25,977 1,950,603 1.35 9.18 238,594 17,915,898

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock C - Conversion 125,067 1,924,626 6.95

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock C - Conversion 541,960 1,799,559 43.09

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock C - Conversion 378,773 1,257,599 43.10

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock C - Conversion 381,733 878,826 76.79

2013-11-20 2013-11-20 4 RLYP Relypsa Inc
Common Stock C - Conversion 497,093 497,093

2013-05-08 2013-05-08 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -100,000 2,045,475 -4.66 8.45 -845,000 17,284,264

2013-05-08 2013-05-06 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -100,000 2,145,475 -4.45 8.70 -870,000 18,665,632

2013-04-22 2013-04-19 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -157,300 2,245,475 -6.55 8.43 -1,326,039 18,929,354

2013-04-22 2013-04-18 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -100,000 2,402,775 -4.00 8.57 -857,000 20,591,782

2013-02-20 2013-02-19 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -300,000 2,502,775 -10.70 6.80 -2,040,000 17,018,870

2013-02-20 2013-02-15 4 MEIP MEI Pharma, Inc.
Common Stock S - Sale -197,225 2,802,775 -6.57 6.60 -1,301,685 18,498,315

2012-12-28 3 MEIP MEI Pharma, Inc.
Common Stock 3,000,000

2012-08-06 2012-08-02 4 WHRT WORLD HEART CORP
Warrants (right to buy) D - Sale to Issuer -2,341,920 0 -100.00 0.10 -233,021

2012-08-06 2012-08-02 4 WHRT WORLD HEART CORP
Common Stock D - Sale to Issuer -6,063,603 0 -100.00

2012-07-26 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Series A Preferred Stock C - Conversion -17,953,008 0 -100.00

2012-07-26 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock P - Purchase 784,313 3,028,439 34.95 9.00 7,058,817 27,255,951

2012-07-26 2012-07-24 4 DRTX Durata Therapeutics, Inc.
Common Stock C - Conversion 2,244,126 2,244,126

2009-02-06 3 TSPT Transcept Pharmaceuticals Inc
Common Stock 1,636,982

P

Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif

S

Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif

A

Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)

C

Penukaran derivatif

D

Penjualan atau pemindahan sekuriti kembali kepada syarikat

F

Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat

G

Hadiah sekuriti oleh atau kepada orang dalam

K

Swap ekuiti dan urus niaga lindung nilai yang serupa

M

Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)

V

Transaksi dilaporkan secara sukarela pada Borang 4

J

Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2018-03-09	IRTC	Lathi Vijay K	84,380	66.3969	84,380	66.3969	5,602,570	47	57.89	-717,812	-12.81
2018-03-08	IRTC	Lathi Vijay K	26,979	66.5004	26,979	66.5004	1,794,114
2018-03-08	IRTC	Lathi Vijay K	2,659	67.1704	2,659	67.1704	178,606
2018-02-22	IRTC	Lathi Vijay K	45,723	65.6133	45,723	65.6133	3,000,037
2018-02-21	IRTC	Lathi Vijay K	44,000	64.1162	44,000	64.1162	2,821,113
2018-02-20	IRTC	Lathi Vijay K	125,000	61.8091	125,000	61.8091	7,726,138
2017-12-07	IRTC	Lathi Vijay K	6,354	52.1495	6,354	52.1495	331,358
2017-12-07	IRTC	Lathi Vijay K	72,000	52.7846	72,000	52.7846	3,800,491
2017-12-06	IRTC	Lathi Vijay K	14,216	52.2855	14,216	52.2855	743,291
2017-12-05	IRTC	Lathi Vijay K	57,430	52.4082	57,430	52.4082	3,009,803
2017-11-17	IRTC	Lathi Vijay K	125,000	52.1102	125,000	52.1102	6,513,775
2017-11-16	IRTC	Lathi Vijay K	100,000	52.0866	100,000	52.0866	5,208,660
2017-09-13	IRTC	Lathi Vijay K	10	45.8240	10	45.8240	458
2017-09-13	IRTC	Lathi Vijay K	34,603	49.5090	34,603	49.5090	1,713,160
2017-06-08	IRTC	Lathi Vijay K	292,000	38.0400	292,000	38.0400	11,107,680
2017-06-06	IRTC	Lathi Vijay K	138,624	36.6300	138,624	36.6300	5,077,797
2017-05-16	IRTC	Lathi Vijay K	80,000	36.2600	80,000	36.2600	2,900,800
2017-05-16	IRTC	Lathi Vijay K	130,000	35.2500	130,000	35.2500	4,582,500
2017-05-15	IRTC	Lathi Vijay K	235,000	34.2500	235,000	34.2500	8,048,750
2017-05-12	IRTC	Lathi Vijay K	200,000	34.2500	200,000	34.2500	6,850,000

Tarikh Dagangan	Simbol Saham	Orang dalam	Saham Dilaporkan	Harga Dilaporkan	Saham Dilaraskan	Harga Dilaraskan	Asas Kos	Hari ke Min	Harga pada Min	Kerugian Maks Dielakkan ($)	Kerugian Maks Dielakkan (%)
2015-03-24	MEIP	New Leaf Ventures II, L.P.	1,601,390	1.9734	80,070	39.4680	3,160,183	323	404	29,187,693	923.61
2014-12-09	MEIP	New Leaf Ventures II, L.P.	70,081	6.0085	3,504	120.1700	421,082
2014-12-08	MEIP	New Leaf Ventures II, L.P.	9,004	6.0523	450	121.0460	54,495
2013-11-21	MEIP	New Leaf Ventures II, L.P.	365,000	8.2500	18,250	165.0000	3,011,250
2013-05-08	MEIP	New Leaf Ventures II, L.P.	100,000	8.4500	5,000	169.0000	845,000
2013-05-06	MEIP	New Leaf Ventures II, L.P.	100,000	8.7000	5,000	174.0000	870,000
2013-04-19	MEIP	New Leaf Ventures II, L.P.	157,300	8.4300	7,865	168.6000	1,326,039
2013-04-18	MEIP	New Leaf Ventures II, L.P.	100,000	8.5700	5,000	171.4000	857,000
2013-02-19	MEIP	New Leaf Ventures II, L.P.	300,000	6.8000	15,000	136.0000	2,040,000
2013-02-15	MEIP	New Leaf Ventures II, L.P.	197,225	6.6000	9,861	132.0000	1,301,685

Tarikh Fail	Tarikh Tran	Borang	Simbol Saham	Sekuriti	Kod	Saham	Baki Saham	Peratus Ubah	Saham harga	Tran Nilai	Baki Nilai
2024-03-11	2024-03-11	4	HARP	Harpoon Therapeutics, Inc. 8.000% Series A Redeemable Preferred Stock	D - Sale to Issuer	-10,000	0	-100.00
2024-03-11	2024-03-11	4	HARP	Harpoon Therapeutics, Inc. Common Stock	D - Sale to Issuer	-395,783	0	-100.00
2024-03-11	2024-03-11	4	HARP	Harpoon Therapeutics, Inc. Common Stock	D - Sale to Issuer	-1,463,386	0	-100.00
2023-10-27	2023-10-25	4	HARP	Harpoon Therapeutics, Inc. Common Stock	P - Purchase	171,500	395,783	76.47
2023-10-27	2023-10-25	4	HARP	Harpoon Therapeutics, Inc. Common Stock	P - Purchase	1,372,000	1,463,386	1,501.32
2023-03-27		3	HARP	Harpoon Therapeutics, Inc. 8.000% Series A Redeemable Preferred Stock			10,000
2023-03-27		3	HARP	Harpoon Therapeutics, Inc. Common Stock			913,860
2023-03-27		3	HARP	Harpoon Therapeutics, Inc. Common Stock			2,242,839
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Series B-2 Preferred Shares	C - Conversion	-148,603	0	-100.00
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Series B-1 Preferred Shares	C - Conversion	-178,230	0	-100.00
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Series A Preferred Shares	C - Conversion	-466,793	0	-100.00
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Ordinary Shares	P - Purchase	384,615	384,615		13.00	4,999,995	4,999,995
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Ordinary Shares	P - Purchase	278,062	1,071,688	35.04	13.00	3,614,806	13,931,944
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Ordinary Shares	C - Conversion	148,603	793,626	23.04
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Ordinary Shares	C - Conversion	178,230	645,023	38.18
2018-05-31	2018-05-30	4	ITRM	Iterum Therapeutics plc Ordinary Shares	C - Conversion	466,793	466,793
2018-03-12	2018-03-09	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-84,380	0	-100.00	66.40	-5,602,570
2018-03-12	2018-03-08	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-2,659	84,380	-3.05	67.17	-178,606	5,667,838
2018-03-12	2018-03-08	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-26,979	87,039	-23.66	66.50	-1,794,114	5,788,128
2018-02-26	2018-02-22	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-45,723	114,018	-28.62	65.61	-3,000,037	7,481,097
2018-02-22	2018-02-21	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-44,000	159,741	-21.60	64.12	-2,821,113	10,241,986
2018-02-22	2018-02-20	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-125,000	203,741	-38.02	61.81	-7,726,138	12,593,048
2017-12-07	2017-12-07	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-72,000	328,741	-17.97	52.78	-3,800,491	17,352,462
2017-12-07	2017-12-07	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-6,354	400,741	-1.56	52.15	-331,358	20,898,443
2017-12-07	2017-12-06	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-14,216	407,095	-3.37	52.29	-743,291	21,285,166
2017-12-07	2017-12-05	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-57,430	421,311	-12.00	52.41	-3,009,803	22,080,151
2017-11-20	2017-11-17	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-125,000	478,741	-20.70	52.11	-6,513,775	24,947,289
2017-11-20	2017-11-16	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-100,000	603,741	-14.21	52.09	-5,208,660	31,446,816
2017-09-15	2017-09-13	4	IRTC	iRhythm Technologies, Inc. Common Stock Warrant (Right to Buy)	X - Other	-72,389	0	-100.00
2017-09-15	2017-09-13	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-34,603	703,741	-4.69	49.51	-1,713,160	34,841,513
2017-09-15	2017-09-13	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-10	738,344	0.00	45.82	-458	33,833,875
2017-09-15	2017-09-13	4	IRTC	iRhythm Technologies, Inc. Common Stock	X - Other	72,389	738,354	10.87
2017-07-07	2017-04-26	4	IRTC	iRhythm Technologies, Inc. Employee Stock Option (right to buy)	A - Award	3,007	3,007
2017-07-07	2017-04-26	4	IRTC	iRhythm Technologies, Inc. Common Stock	A - Award	1,405	1,405
2017-06-08	2017-06-08	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-292,000	665,965	-30.48	38.04	-11,107,680	25,333,309
2017-06-08	2017-06-06	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-138,624	957,965	-12.64	36.63	-5,077,797	35,090,258
2017-05-16	2017-05-16	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-130,000	1,096,589	-10.60	35.25	-4,582,500	38,654,762
2017-05-16	2017-05-16	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-80,000	1,226,589	-6.12	36.26	-2,900,800	44,476,117
2017-05-16	2017-05-15	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-235,000	1,306,589	-15.24	34.25	-8,048,750	44,750,673
2017-05-16	2017-05-12	4	IRTC	iRhythm Technologies, Inc. Common Stock	S - Sale	-200,000	1,541,589	-11.48	34.25	-6,850,000	52,799,423
2016-10-25	2016-10-25	4	IRTC	iRhythm Technologies, Inc. Series D Preferred Stock Warrant (Right to Buy)	C - Conversion	-72,389	0	-100.00
2016-10-25	2016-10-25	4	IRTC	iRhythm Technologies, Inc. Series E Convertible Preferred Stock	C - Conversion	-155,548	0	-100.00
2016-10-25	2016-10-25	4	IRTC	iRhythm Technologies, Inc. Series D Convertible Preferred Stock	C - Conversion	-190,154	0	-100.00
2016-10-25	2016-10-25	4	IRTC	iRhythm Technologies, Inc. Series C Convertible Preferred Stock	C - Conversion	-610,136	0	-100.00
2016-10-25	2016-10-25	4	IRTC	iRhythm Technologies, Inc. Common Stock	P - Purchase	25,000	1,741,589	1.46	17.00	425,000	29,607,013
2016-10-25	2016-10-25	4	IRTC	iRhythm Technologies, Inc. Common Stock	C - Conversion	1,716,589	1,716,589
2015-03-26	2015-03-24	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-1,601,390	0	-100.00	1.97	-3,160,183
2014-12-22	2014-12-18	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-150,000	2,409,374	-5.86	19.01	-2,851,845	45,807,741
2014-12-10	2014-12-09	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-70,081	1,601,390	-4.19	6.01	-421,082	9,621,952
2014-12-10	2014-12-08	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-9,004	1,671,471	-0.54	6.05	-54,495	10,116,244
2014-11-18	2014-11-17	4	DRTX	Durata Therapeutics, Inc. Common Stock	D - Sale to Issuer	-3,028,439	0	-100.00
2014-11-13	2014-11-11	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-800,000	2,559,374	-23.81	19.37	-15,496,000	49,575,074
2014-10-01	2014-09-29	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-12,556	3,359,374	-0.37	20.02	-251,331	67,243,917
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Series B Convertible Preferred Stock	C - Conversion	-759,565	0	-100.00
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Warrant	X - Other	-759,565	0	-100.00
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Series E Convertible Preferred Stock	C - Conversion	-3,546,094	0	-100.00
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Series D2 Convertible Preferred Stock	C - Conversion	-1,349,433	0	-100.00
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Series D1 Convertible Preferred Stock	C - Conversion	-3,050,019	0	-100.00
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Series C Convertible Preferred Stock	C - Conversion	-8,439,620	0	-100.00
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Series B Convertible Preferred Stock	C - Conversion	-20,942,466	0	-100.00
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Common Stock	P - Purchase	60,000	3,371,930	1.81	21.02	1,261,200	70,877,969
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Common Stock	C - Conversion	66,049	3,311,930	2.03
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Common Stock	C - Conversion	308,356	3,245,881	10.50
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Common Stock	C - Conversion	117,342	2,937,525	4.16
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Common Stock	C - Conversion	265,219	2,820,183	10.38
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Common Stock	C - Conversion	733,880	2,554,964	40.30
2014-03-28	2014-03-27	4	VSAR	Versartis, Inc. Common Stock	C - Conversion	1,821,084	1,821,084
2014-03-20	2014-03-18	4	CMRX	CHIMERIX INC Common Stock	J - Other	-700,000	1,543,394	-31.20
2014-02-21	2014-02-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Series C Preferred Stock	C - Conversion	77,522	0	-100.00
2014-02-21	2014-02-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Series B Preferred Stock	C - Conversion	442,478	0	-100.00
2014-02-21	2014-02-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock	C - Conversion	13,721	107,327	14.66
2014-02-21	2014-02-19	4	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock	C - Conversion	78,315	93,606	512.16
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2014-02-12		3	CNCE	CONCERT PHARMACEUTICALS, INC. Common Stock			30,582
2013-11-25	2013-11-21	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-365,000	1,680,475	-17.84	8.25	-3,011,250	13,863,919
2013-11-21		3	OXFD	Oxford Immunotec Global PLC Ordinary Shares			1,377,497
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Warrant to Purchase Common Stock	M - Exercise	-25,977	0	-100.00
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Warrant to Purchase Common Stock	J - Other	25,977	25,977
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Warrant to Purchase Preferred Stock	J - Other	-17,671	0	-100.00
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Series C-2 Preferred Stock	C - Conversion	-125,067	0	-100.00
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Series C-1 Preferred Stock	C - Conversion	-541,960	0	-100.00
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Series B-2 Preferred Stock	C - Conversion	-378,773	0	-100.00
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Series B-1 Preferred Stock	C - Conversion	-259,676	0	-100.00
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Series A-1 Preferred Stock	C - Conversion	-497,093	0	-100.00
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	P - Purchase	185,978	2,114,890	9.64	11.00	2,045,758	23,263,790
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	F - Taxes	-21,691	1,928,912	-1.11	11.00	-238,601	21,218,032
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	M - Exercise	25,977	1,950,603	1.35	9.18	238,594	17,915,898
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	C - Conversion	125,067	1,924,626	6.95
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	C - Conversion	541,960	1,799,559	43.09
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	C - Conversion	378,773	1,257,599	43.10
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	C - Conversion	381,733	878,826	76.79
2013-11-20	2013-11-20	4	RLYP	Relypsa Inc Common Stock	C - Conversion	497,093	497,093
2013-05-08	2013-05-08	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-100,000	2,045,475	-4.66	8.45	-845,000	17,284,264
2013-05-08	2013-05-06	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-100,000	2,145,475	-4.45	8.70	-870,000	18,665,632
2013-04-22	2013-04-19	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-157,300	2,245,475	-6.55	8.43	-1,326,039	18,929,354
2013-04-22	2013-04-18	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-100,000	2,402,775	-4.00	8.57	-857,000	20,591,782
2013-02-20	2013-02-19	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-300,000	2,502,775	-10.70	6.80	-2,040,000	17,018,870
2013-02-20	2013-02-15	4	MEIP	MEI Pharma, Inc. Common Stock	S - Sale	-197,225	2,802,775	-6.57	6.60	-1,301,685	18,498,315
2012-12-28		3	MEIP	MEI Pharma, Inc. Common Stock			3,000,000
2012-08-06	2012-08-02	4	WHRT	WORLD HEART CORP Warrants (right to buy)	D - Sale to Issuer	-2,341,920	0	-100.00	0.10	-233,021
2012-08-06	2012-08-02	4	WHRT	WORLD HEART CORP Common Stock	D - Sale to Issuer	-6,063,603	0	-100.00
2012-07-26	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Series A Preferred Stock	C - Conversion	-17,953,008	0	-100.00
2012-07-26	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Common Stock	P - Purchase	784,313	3,028,439	34.95	9.00	7,058,817	27,255,951
2012-07-26	2012-07-24	4	DRTX	Durata Therapeutics, Inc. Common Stock	C - Conversion	2,244,126	2,244,126
2009-02-06		3	TSPT	Transcept Pharmaceuticals Inc Common Stock			1,636,982